BFM
VIVS

Boston Financial Management’s VivoSim Labs VIVS Stock Holding History

Boston Financial Management’s Portfolio VIVS Stock Details VIVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-44
Closed -$14K – 271
2017
Q4 		$14K Sell
44
-45
-51% -$16.7K ﹤0.01% 262
2017
Q3 		$47K Hold
89
– – ﹤0.01% 258
2017
Q2 		$56K Hold
89
– – ﹤0.01% 269
2017
Q1 		$68K Hold
89
– – 0.01% 274
2016
Q4 		$72K Hold
89
– – 0.01% 267
2016
Q3 		$81K Hold
89
– – 0.01% 251
2016
Q2 		$79K Buy
+89
New +$59.7K 0.01% 244

Other funds holding VIVS

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Boston Financial Management's VIVS Position: Q1 2018 in Review

Boston Financial Management sold out of VivoSim Labs (VIVS) in Q1 2018, closing a stake of 44 shares — an estimated $14K sold.

Boston Financial Management first reported a position in VIVS in Q2 2016 and held it in 7 quarters. The position peaked at $81K in Q3 2016. 105 funds tracked by Wall St. Rank hold VIVS as of Q1 2018.

  • Boston Financial Management reported no remaining VivoSim Labs position as of Q1 2018 after selling out during the quarter.
  • Boston Financial Management sold 44 VivoSim Labs shares in Q1 2018, an estimated $14K.
  • Boston Financial Management first reported a position in VivoSim Labs in Q2 2016 and held it in 7 quarters.
  • Boston Financial Management's VivoSim Labs position peaked at $81K in Q3 2016.
  • 105 funds tracked by Wall St. Rank held VivoSim Labs as of Q1 2018.

Based on Boston Financial Management's 13F filing for Q1 2018, filed 25 Apr 2018.